Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders

NCT00101764 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

120

Enrollment

NIH

Sponsor class

Conditions

Macular Degeneration
Retinal Vein Occlusion
Diabetic Retinopathy

Interventions

DRUG: Triamcinolone Acetonide

Sponsor

National Eye Institute (NEI)